BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9496567)

  • 1. [Treatment of hepatitis C with interferon-alpha in hemodialysis patients].
    Degos F
    Nephrologie; 1997; 18(7):279-80. PubMed ID: 9496567
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy with interferon plus ribavirin in hemodialysis patient with PCR-positive viral hepatitis C].
    Arambarri M; Fernández Lucas M; Echarri R; Teruel JL; Alarcón C; Merino JL; Ortuño J
    Nefrologia; 2004; 24 Suppl 3():39-42. PubMed ID: 15219067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis C infection among patients receiving hemodialysis].
    Kamar N; Izopet J; Rostaing L
    Nephrologie; 2003; 24(3):133-41. PubMed ID: 12814060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferon-alpha in chronic hepatitis C].
    Swobodnik W
    Dtsch Med Wochenschr; 1995 Aug; 120(34-35):1186. PubMed ID: 7656857
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complete cytogenetic response to interferon-alpha in a patient with chronic myelogenous leukemia undergoing hemodialysis].
    Doi S; Edamura S; Akasaka H; Kawamura M; Arima N; Nasu K
    Rinsho Ketsueki; 2001 Jul; 42(7):549-53. PubMed ID: 11524845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon may be useful in hemodialysis patients with hepatitis C virus chronic infection who are candidates for kidney transplant.
    Casanovas Taltavull T; Baliellas C; Sesé E; Iborra MJ; Benasco C; Andrés E; González MT; Gil-Vernet S; Casanova A; Casais LA
    Transplant Proc; 1995 Aug; 27(4):2229-30. PubMed ID: 7652784
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and tolerance of interferon-alpha in the treatment of chronic hepatitis C in end-stage renal disease patients on hemodialysis.
    Rocha CM; Perez RM; Ferreira AP; Carvalho-Filho RJ; Pace FH; Silva IS; Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
    Liver Int; 2006 Apr; 26(3):305-10. PubMed ID: 16584392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of interferon alpha in acute hepatitis C in patients on chronic hemodialysis.
    Süleymanlar I; Sezer T; Işitan F; Yakupoglu G; Süleymanlar G
    Nephron; 1998; 79(3):353-4. PubMed ID: 9678442
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interferon therapy in cildren with chronic hepatitis and chronic renal failure treated with dialysis].
    Szczepańska M; Szprynger K; Morawiec-Knysak A; Schneiberg B; Augustyn-Iwachów T; Dyduch A
    Pol Merkur Lekarski; 2000 Sep; 9 Suppl 1():33-6. PubMed ID: 11081342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [When should the treatment with interferon alpha be discontinued in chronic hepatitis C?].
    Castilla Cortázar A
    Med Clin (Barc); 1993 Dec; 101(20):774-6. PubMed ID: 8114538
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatitis C].
    Viola LA; Fernández JL
    Acta Gastroenterol Latinoam; 1992; 22(2):133-4. PubMed ID: 1338677
    [No Abstract]   [Full Text] [Related]  

  • 13. [Predictive factors of response to interferon-alpha treatment in chronic hepatitis C].
    Buti M; Esteban R
    Rev Esp Enferm Dig; 1997 Jul; 89(7):501-2. PubMed ID: 9303619
    [No Abstract]   [Full Text] [Related]  

  • 14. [Epidemiology of HBV infections and possibilities for therapeutic actions in children and adolescents with end-stage renal failure treated with dialysis].
    Zwolińska D; Inglot M; Makulska I; Gładysz A; Szprynger K; Szczepańska M; Pietrzyk J; Zachwieja K; Zurowska A; Zachwieja J; Rajkowski T; Jobs K; Latoszyńska J; Jander A
    Pol Merkur Lekarski; 2001 Apr; 10(58):267-70. PubMed ID: 11434173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to alpha 2B interferon (IFN) treatment in a haemodialysis patient with chronic hepatitis C.
    Barril G; Schez Tomero JA; Garcia Buey L; Motellon JL; Bernis C; Traver JA
    Nephrol Dial Transplant; 1994; 9(9):1354-5. PubMed ID: 7816309
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatitis C--clinical aspects, diagnosis and therapy].
    Mörl M
    Fortschr Med; 1997 Jan; 115(3):26-9. PubMed ID: 9102384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
    Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
    Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance and efficacy of interferon-alpha in hemodialysis patients in Tripoli.
    Buargub M; El Huni S; Tagdi M
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):338-43. PubMed ID: 16970253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between alpha-interferon and erythropoietin in antiviral and antineoplastic therapy in uraemic patients on haemodialysis.
    Nordio M; Guarda L; Lorenzi S; Lombini C; Marchini P; Mirandoli F
    Nephrol Dial Transplant; 1993; 8(11):1308. PubMed ID: 8302480
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis.
    Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Kashiwagi S; Nakamura S; Fujishima M
    Fukuoka Igaku Zasshi; 1998 Aug; 89(8):232-7. PubMed ID: 9778915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.